Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Disease Biomarkers

Cristiana Tanase's Biography

Cristiana Tanase, Proteomics Group Leader, "Victor Babes" National Institute of Pathology

Cristiana Tanase – MD, PhD in Medicine, Senior Researcher, Proteomics Group Leader (“Victor Babes” National Institute of Pathology) - was involved in over 60 national and international research projects, a significant number in pathology, proteomics, biomarkers, toxicology.
The major fields of activity cover development and implementation of techniques for detection of biomarkers (cytokines, chemokines, growth factors, signal transduction molecules, protein profiling, nucleic acids) in tumor pathology research. The set of techniques includes multiplex analysis using xMAP technology (Luminex), SELDI-TOF, 2D-electrophoresis, on-chip electrophoresis (proteins, nucleic acids). Accordingly, in the last years, the main publications were focused on molecular pathology associated to cancer development. She is reviewer for 6 international journals and board member for “Recent Patents on Biomarkers” and “Journal of Immunoassay & Immunochemistry”. She is expert evaluator for FP7, EuroNanoMed and NCP Health FP7.

Cristiana Tanase Image

Signalling Molecules as Proteomic Biomarkers in Brain Tumours

Thursday, 10 May 2012 at 09:30

Add to Calendar ▼2012-05-10 09:30:002012-05-10 10:30:00Europe/LondonSignalling Molecules as Proteomic Biomarkers in Brain Tumours

A recent discovery in the field of brain tumour pathogenesis is represented by dysregulated signalling pathways. In order to identify new biomarkers and therapeutic targets, monitoring an array of signalling molecules in tumours versus peritumoral tissue provides a better understanding of the events in brain tumour progression.

Add to Calendar ▼2012-05-10 00:00:002012-05-11 00:00:00Europe/LondonDisease